Therapeutic Strategies for Diabetic Kidney Disease
نویسندگان
چکیده
منابع مشابه
Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
Diabetes is a worldwide epidemic that has led to a rise in diabetic kidney disease (DKD). Over the past two decades, there has been significant clarification of the various pathways implicated in the pathogenesis of DKD. Nonetheless, very little has changed in the way clinicians manage patients with this disorder. Indeed, treatment is primarily centered on controlling hyperglycemia and hyperten...
متن کاملTherapeutic management of diabetic kidney disease
During the past 10 years, a global pandemic of end-stage renal disease (ESRD) attributed to diabetes mellitus has changed the therapeutic strategies based on landmark trials that have shown that diabetic micro- and macrovascular complications might be preventable. However, the remaining risk of the progression of diabetic kidney disease to ESRD is still high, despite newly introduced anti-diabe...
متن کاملNon-albuminuric Diabetic Kidney Disease in Diabetic Patients: A Review
Introduction: The constantly increasing incidence of type 2 diabetes, probably due to obesity and sedentary life, has led to the increased incidence of macro- and microvascular diabetic complications such as nephropathy. Despite the prompt efforts to develop effective treatments for diabetes and slow the progression of its complications, it is still reported as the most common cause of chronic ...
متن کاملDiabetic kidney disease
Screening for various medical conditions is believed to be cost effective when it is targeted at vulnerable or susceptible groups. This proposition, it could be argued, is no more appropriate than screening for chronic kidney disease in people with existing diabetes. The prevalence of CKD in the UK general population is probably around 6%; in patients with diabetes it’s closer to 30%.Of course,...
متن کاملAntioxidant Therapy for Diabetic Kidney Disease
Diabetic kidney disease (DKD) is the single most common cause of end stage renal disease (ESRD) with the annual costs of caring for patients with DKD exceeding more than $9 billion in the United States (Centers of Disease Control and Prevention, 2005). Every diabetic patient has up to a 40% lifetime risk to develop DKD, if the patient does not die prematurely of cardiovascular disease (CVD) (Pa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetology
سال: 2021
ISSN: 2673-4540
DOI: 10.3390/diabetology2010003